46 results on '"Ibrahim, Nasrien"'
Search Results
2. HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
3. Cardiomyopathies in Pregnancy: Trends and Clinical Outcomes in Delivery Hospitalizations in the United States (2005-2020)
4. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America
5. Organ Donation and Transplantation among Non-US Citizens: Opportunities to Improve Global Equity in Heart Transplantation
6. Temporal Changes in Racial and Ethnic Disparities in the Utilization of Left Atrial Appendage Occlusion in the United States
7. Sex-Related Differences in Patient Characteristics, Hemodynamics, and Outcomes of Cardiogenic Shock: INOVA-SHOCK Registry
8. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy
9. A Standardized and Regionalized Network of Care for Cardiogenic Shock
10. The Impact of Health Care Disparities on Patients With Heart Failure
11. Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study
12. Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock
13. Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes
14. Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction
15. Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction
16. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea
17. Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper
18. Gender differences in industry payments among cardiologists
19. Readability and Accessibility of Patient-Education Materials for Heart Failure in the United States
20. Financial Toxicities Associated With Patient Parking: Heart Transplantation as a Case Study
21. Blood kidney injury molecule–1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography—Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study
22. The Wallet Biopsy: Medical Crowdfunding for Heart Transplantation
23. Serial Heart Rates, Guideline-Directed Beta Blocker Use, and Outcomes in Patients With Chronic Heart Failure With Reduced Ejection Fraction
24. Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study)
25. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study
26. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy
27. The Gatekeepers to Transplantation: Who Are We Keeping Out?
28. Physical Activity Levels And Cardiac Functional Capacity In Patients With Diabetic Cardiomyopathy: Baseline Analysis From The Arise-HF Trial
29. Racial And Ethnic Disparities In The Contemporary Utilization Of Left Ventricular Assist Devices In The United States
30. Are Implantable Hemodynamic Monitors Accessible To Patients Regardless Of Their Socioeconomic Status? A National Multicenter Retrospective Cohort Study
31. 33 - Biomarkers and Precision Medicine in Heart Failure
32. Shock Protocols May Decrease Racial, Ethnic, and Sex Disparities in Acute Myocardial Infarction and Cardiogenic Shock
33. CRT-100.38 Shock Protocols May Decrease Racial, Ethnic, and Sex Disparities in Acute Myocardial Infarction and Cardiogenic Shock
34. A Look Back, A Path Forward: Moving Toward Diversity and Inclusion in Cardiovascular Society Presidents
35. Personalizing Comprehensive Disease-Modifying Therapy: Obstacles and Opportunities
36. From Clinical Trials to Communities: The 5 C’s of Ensuring Equitable Delivery of Heart Failure Therapies
37. Don’t Be So Fast to Discard That Clean Catch!
38. How Feeling Like an Imposter Can Impede Your Success
39. Promoting Health Equity in Heart Failure Amid a Pandemic
40. Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction
41. Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients with Heart Failure with Reduced Ejection Fraction Treated with Sacubitril/valsartan
42. Sex-based Differences in Biomarkers, Quality of Life, and Reverse Cardiac Remodeling in Patients with Heart Failure with Reduced Ejection Fraction Treated with Sacubitril/valsartan
43. Contributors
44. First Experience with Feasibility and Implementation of the Smartphone Habits Heart® App: A Proof-of-Concept Study for Patient Engagement in Heart Failure Management
45. 133 - Patients with Heart Failure with Mid-Range Ejection Fraction Have a Distinct Clinical Profile: An Analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry
46. 132 - Addition or Removal of Guideline Directed Medical Therapy in Ambulatory Patients with Heart Failure with Reduced Ejection Fraction Relative to Change in Symptom Severity. An Analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.